Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2025)

Monte Rosa Therapeutics' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.27 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 35.69% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, up 35.69%, while the annual FY2025 figure was 0.28, 36.83% up from the prior year.
  • Asset Utilization Ratio reached 0.27 in Q4 2025 per GLUE's latest filing, down from 0.44 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.47 in Q2 2025 to a low of 0.0 in Q1 2024.